These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver Disease. Mesarwi OA; Loomba R; Malhotra A Am J Respir Crit Care Med; 2019 Apr; 199(7):830-841. PubMed ID: 30422676 [TBL] [Abstract][Full Text] [Related]
4. Effect of CPAP therapy on liver disease in patients with OSA: a review. Liu X; Miao Y; Wu F; Du T; Zhang Q Sleep Breath; 2018 Dec; 22(4):963-972. PubMed ID: 29327118 [TBL] [Abstract][Full Text] [Related]
5. Treating Obstructive Sleep Apnea and Chronic Intermittent Hypoxia Improves the Severity of Nonalcoholic Fatty Liver Disease in Children. Sundaram SS; Halbower AC; Klawitter J; Pan Z; Robbins K; Capocelli KE; Sokol RJ J Pediatr; 2018 Jul; 198():67-75.e1. PubMed ID: 29752170 [TBL] [Abstract][Full Text] [Related]
6. Continuous Positive Airway Pressure Does Not Improve Nonalcoholic Fatty Liver Disease in Patients with Obstructive Sleep Apnea. A Randomized Clinical Trial. Ng SSS; Wong VWS; Wong GLH; Chu WCW; Chan TO; To KW; Ko FWS; Chan KP; Hui DS Am J Respir Crit Care Med; 2021 Feb; 203(4):493-501. PubMed ID: 32926803 [No Abstract] [Full Text] [Related]
7. Continuous Positive Airway Pressure Therapy on Nonalcoholic Fatty Liver Disease in Patients With Obstructive Sleep Apnea. Kim D; Ahmed A; Kushida C J Clin Sleep Med; 2018 Aug; 14(8):1315-1322. PubMed ID: 30092894 [TBL] [Abstract][Full Text] [Related]
8. Association between continuous positive airway pressure and serum aminotransferases in patients with obstructive sleep apnea. Chen LD; Zhang LJ; Lin XJ; Qi JC; Li H; Wu Z; Xu QZ; Huang YP; Lin L Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):587-594. PubMed ID: 29224042 [TBL] [Abstract][Full Text] [Related]
9. Impact of effective versus sham continuous positive airway pressure on liver injury in obstructive sleep apnoea: Data from randomized trials. Jullian-Desayes I; Tamisier R; Zarski JP; Aron-Wisnewsky J; Launois-Rollinat SH; Trocme C; Levy P; Joyeux-Faure M; Pepin JL Respirology; 2016 Feb; 21(2):378-85. PubMed ID: 26567858 [TBL] [Abstract][Full Text] [Related]
10. Association between non-alcoholic fatty liver disease and obstructive sleep apnea. Umbro I; Fabiani V; Fabiani M; Angelico F; Del Ben M World J Gastroenterol; 2020 May; 26(20):2669-2681. PubMed ID: 32523319 [TBL] [Abstract][Full Text] [Related]
11. Sleep apnea: An overlooked cause of lipotoxicity? Gu C; Younas H; Jun JC Med Hypotheses; 2017 Oct; 108():161-165. PubMed ID: 29055392 [TBL] [Abstract][Full Text] [Related]
12. Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. Aron-Wisnewsky J; Minville C; Tordjman J; Lévy P; Bouillot JL; Basdevant A; Bedossa P; Clément K; Pépin JL J Hepatol; 2012 Jan; 56(1):225-33. PubMed ID: 21703181 [TBL] [Abstract][Full Text] [Related]
13. Lysyl Oxidase as a Serum Biomarker of Liver Fibrosis in Patients with Severe Obesity and Obstructive Sleep Apnea. Mesarwi OA; Shin MK; Drager LF; Bevans-Fonti S; Jun JC; Putcha N; Torbenson MS; Pedrosa RP; Lorenzi-Filho G; Steele KE; Schweitzer MA; Magnuson TH; Lidor AO; Schwartz AR; Polotsky VY Sleep; 2015 Oct; 38(10):1583-91. PubMed ID: 26085300 [TBL] [Abstract][Full Text] [Related]
14. The impact of obstructive sleep apnea on nonalcoholic fatty liver disease in patients with severe obesity. Benotti P; Wood GC; Argyropoulos G; Pack A; Keenan BT; Gao X; Gerhard G; Still C Obesity (Silver Spring); 2016 Apr; 24(4):871-7. PubMed ID: 26880657 [TBL] [Abstract][Full Text] [Related]
15. Effect of Supplemental Oxygen on Blood Pressure in Obstructive Sleep Apnea (SOX). A Randomized Continuous Positive Airway Pressure Withdrawal Trial. Turnbull CD; Sen D; Kohler M; Petousi N; Stradling JR Am J Respir Crit Care Med; 2019 Jan; 199(2):211-219. PubMed ID: 30025470 [TBL] [Abstract][Full Text] [Related]